Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens
Year: 2012
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: OBJECTIVE: The benefits of real-time continuous glucose monitoring (CGM) have been demonstrated in patients with type 1 diabetes. Our aim was to compare the effect of two modes of use of CGM, patient led or physician driven, for 1 year in subjects with poorly controlled type 1 diabetes. RESEARCH DESIGN AND METHODS: Patients with type 1 diabetes aged 8-60 years with HbA(1c) ≥ 8% were randomly assigned to three groups (1:1:1). Outcomes for glucose control were assessed at 1 year for two modes of CGM (group 1: patient led; group 2: physician driven) versus conventional self-monitoring of blood glucose (group 3: control). RESULTS: A total of 257 subjects with type 1 diabetes underwent screening. Of these, 197 were randomized, with 178 patients completing the study (age: 36 ± 14 years; HbA(1c): 8.9 ± 0.9%). HbA(1c) improved similarly in both CGM groups and was reduced compared with the control group (group 1 vs. group 3: -0.52%, P = 0.0006; group 2 vs. group 3: -0.47%, P = 0.0008; groups 1 + 2 vs. group 3: -0.50%, P < 0.0001). The incidence of hypoglycemia was similar in the three groups. Patient SF-36 questionnaire physical health score improved in both experimental CGM groups (P = 0.004). Sensor consumption was 34% lower in group 2 than in group 1 (median [Q1-Q3] consumption: group 1: 3.42/month [2.20-3.91] vs. group 2: 2.25/month [1.27-2.99], P = 0.001). CONCLUSIONS: Both patient-led and physician-driven CGM provide similar long-term improvement in glucose control in patients with poorly controlled type 1 diabetes, but the physician-driven CGM mode used fewer sensors.
Source: Diabetes Care
DOI: 10.2337/dc11-2021
Authors: Jean-Pierre Riveline, Pauline Schaepelynck, Lucy Chaillous, Eric Renard, Agnès Sola-Gazagnes, Alfred Penfornis, Nadia Tubiana-Rufi, Véronique Sulmont, Bogdan Catargi, Céline Lukas, Régis P. Radermecker, Charles Thivolet, François Moreau, Pierre-Yves Benhamou, Bruno Guerci, Anne-Marie Leguerrier, Luc Millot, Claude Sachon, Guillaume Charpentier, Hélène Hanaire, for the EVADIAC Sensor Study Group
Institutions: Centre Hospitalier Sud Francilien, Université Pierre-et-Marie-Curie, Hôpital Sainte-Marguerite, Centre Hospitalier Universitaire de Nantes, Institut du Thorax, Inserm, Centre Hospitalier Universitaire de Montpellier, Assistance Publique – Hôpitaux de Paris, Hôtel-Dieu de Paris, Centre Hospitalier Universitaire de Besançon, Université de Franche-Comté, Hôpital Robert-Debré, Centre Hospitalier Universitaire de Reims, Centre Hospitalier Universitaire de Bordeaux, University of Liège, Centre Hospitalier Universitaire de Liège, Lyon 1 Université, Hospices Civils de Lyon, Hôpital Lyon Sud, Hôpitaux Universitaires de Strasbourg, Université Joseph Fourier, Centre Hospitalier Universitaire de Grenoble, Centre Hospitalier Régional et Universitaire de Nancy, Centre Hospitalier Universitaire de Rennes, Centre Hospitalier Universitaire de Saint-Étienne, Pitié-Salpêtrière Hospital, Centre Hospitalier Universitaire de Toulouse, Université de Toulouse
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W1987616068
